3 withdrawn. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Withdrawn 3 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Coronavirus: new trials by email Literature Review of Coronavirus trials Research Report on Coronavirus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19 CVnCoV Vaccine - Coronavirus, Covid19 | Phase 3 | Withdrawn | CureVac | 2021-10-01 | 2021-08-20 | |
| A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine UB-612, Placebo - Covid-19, SARS-CoV-2 | Phase 2 / Phase 3 | Withdrawn | Vaxxinity, Inc. | 2021-02-01 | 2022-04-04 | |
| A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19 EQ001, EQ001 Placebo - Coronavirus | Phase 3 | Withdrawn | Biocon Limited | 2020-11-01 | 2026-05-12 |
COVID-19 (3) · Coronavirus Infections (3) · Severe Acute Respiratory Syndrome (1)
Coronaviridae Infections (3) · Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pneumonia (3) · Pneumonia, Viral (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Virus Diseases (3)
CVnCoV COVID-19 vaccine (1) · UB-612 COVID-19 vaccine (1) · itolizumab (1)
Biocon Limited (1) · CureVac (1) · Vaxxinity, Inc. (1)
Colombia (1)
Gray Heppner (1) · Maple Fung, MD (1)